This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.

The Epoch Times
The Epoch Times
Focus

Bristol-Myers

LATEST

Business
Business
|
Reuters

Bristol Myers Boosts Cancer Drug Portfolio With $4.1 Billion Turning Point Deal

Jun 04, 2022
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
Bristol Myers Boosts Cancer Drug Portfolio With $4.1 Billion Turning Point Deal
Jun 04
|
FacebookXTruthGettrLinkedInTelegramEmail
Health News
Health News
|
Reuters

Bristol Myers Drug Wins First US Approval for Graft Versus Host Disease Prevention

Dec 15, 2021
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
Bristol Myers Drug Wins First US Approval for Graft Versus Host Disease Prevention
Dec 15
|
FacebookXTruthGettrLinkedInTelegramEmail
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.